Journal der Deutschen Dermatologischen Gesellschaft
Journal Abbreviation: J DTSCH DERMATOL GES
ISSN: 1610-0387
eISSN: 1610-0379
Publisher: Wiley-Blackwell
Publications (304)
Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry (2022)
Mohr P, Scherrer E, Alar V, Assaf C, Beissert S, Berking C, Eigentler T, et al.
Conference contribution
Predictors of long-term survival of stage IV melanoma patients: a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG (2022)
Placke JM, Mohr P, Bluhm L, Kahler K, Weichenthal M, Meier F, Garzarolli M, et al.
Conference contribution
Therapy Management of the first Recurrence after adjuvant Therapy in Stage III: multicenter real-world Data (2022)
Lodde G, Forschner A, Hassel JC, Wulfken LM, Meier F, Mohr P, Kaehler K, et al.
Conference contribution
Effectiveness and Safety of Dabrafenib and Trametinib in Patients with BRAFV600 Mutated Metastatic Melanoma in the Real-World Setting - Final Results of the Non-Interventional COMBI-r Study (2022)
Berking C, Livingstone E, Weichenthal M, Leiter-Stoeppke U, Remy J, Eigentler T, Mohr P, et al.
Conference contribution
Patient preferences of German and Swiss melanoma patients with regard to life-threatening side effects in the context of adjuvant immunotherapy - a qualitative GerMelaTox-A substudy (2022)
Peters W, Maul LV, Huning S, Hassel JC, Heinzerling L, Loquai C, Gutzmer R, et al.
Conference contribution
Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study (2022)
Salzmann M, Wald A, Stege H, Loquai C, Zimmer L, Hayani K, Heinzerling L, et al.
Conference contribution
Which patients should receive adjuvant treatment - an analysis of stage IIA-IIIA patients of the CMMR (2022)
Leiter-Stoppke U, Keim U, Amaral T, Forschner A, Berking C, Gesierich A, Gutzmer R, et al.
Conference contribution
The quality of national skin cancer screening from the perspective of general practitioners: A questionnaire-based comparison between Saxony and Bavaria (SaBaScreen) (2022)
Strasser C, Reinhardt L, Steeb T, Wessely A, Schelling J, Petzold A, Heppt M, et al.
Conference contribution
A novel splice variant of Argonaut 2 affects microRNA target genes and cell viability of melanoma cells (2022)
Linck-Paulus L, Horn A, Matthies AO, Fischer S, Meister G, Sticht H, Kappelmann-Fenzl M, Boßerhoff AK
Conference contribution
SOX10-based drug repurposing identifies novel therapeutic targets in uveal melanoma (2022)
Wessely A, Kammerbauer C, Lischer C, Weich A, Vera J, Berking C, Heppt M
Conference contribution